LCI Lannett Co., Inc.

All LCI filings Filing statistics SEC Website

Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Philadelphia, PA.

Company profile

Ticker

LCI

Exchange

NYSE

CEO

Timothy C. Crew

Incorporated in

Delaware

Location

Pennsylvania

Fiscal year end

Jun 30

Sector

Health Technology > Pharmaceuticals: Major

Industry (SEC)

Pharmaceutical Preparations

Pfizer • Johnson & Johnson • Merck & Co. • Warner Chilcott • Teva Pharmaceutical Industries • Abbott Laboratories • Lilly Eli & Co • Bristol Myers Squibb • AbbVie • Mylan ...

SEC CIK

0000057725

Corporate docs

Articles of Incorporation & Bylaws

Subsidiary Companies

IRS number

230787699

LCI stock data

S&P 500

1M 1Y 2Y 5Y

Company financial data Financial data

Chart LCI financial data

Download latest Excel data (2019 FY) View latest Excel data (2019 FY)

Quarter (USD)	Jun 19	Mar 19	Dec 18	Sep 18
Revenue	133.84M	172.79M	193.72M	155.05M
Net income	-7.59M	10.65M	12.36M	-287.53M
Diluted EPS	-0.2	0.27	0.32	-7.65
Net profit margin	-5.67%	6.16%	6.38%	-185%
Operating income	9.4M	33.38M	36.68M	-341.78M
Net change in cash	-64.96M	41.43M	13.45M	51.74M
Cash on hand	140.25M	205.21M	163.77M	150.33M
Cost of revenue

Annual (USD)	Jun 19	Jun 18	Jun 17	Jun 16
Revenue	655.41M	684.56M	633.34M	542.49M
Net income	-272.11M	28.69M	-581K	44.78M
Diluted EPS	-7.2	0.75	-0.02	1.2
Net profit margin	-41.52%	4.19%	-0.09%	8.25%
Operating income	-262.32M	129.7M	86.45M	130.76M
Net change in cash	41.66M	-19.15M	-107.03M	24.43M
Cash on hand	140.25M	98.59M	117.74M	224.77M
Cost of revenue

Financial data from Lannett earnings reports

Financial report summary

Competition

Mylan • Teva Pharmaceutical Industries • Teva Pharmaceutical Industries • Teva Pharmaceutical Industries • Impax Laboratories • Mylan • Mylan • Mylan

Content analysis ?

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: Aceto, Adderall, adult, Africa, aimed, Akorn, Alabama, Amira, Amphetamine, arrhythmia, ASP, Assertio, Atigall, augmenting, back, belonging, Bentyl, BioPharm, BLA, blocker, Brother, calcium, Cambrex, Carolina, Catalent, CD, Cediprof, choose, clarity, CNS, colution, convicted, counter, County, crime, CRL, cum, curbing, daily, Dicyclomine, duration, eleven, Elite, enriched, enrichment, estate, evidenced, field, footnote, Georgia, glargine, GmbH, GMP, grew, horizontal, hypersecretory, incipient, Inquiry, Interbank, Intercept, IQVIA, Kozloski, Lanham, Lastly, laude, Levitra, London, LSV, magna, mail, main, male, Melissa, Metadate, mismanagement, Momenta, Montana, MVR, nimbler, Noxafil, Opportunistically, opposition, outpatient, outreach, overreaching, pathologic, pathological, payout, PDUFA, penalize, pertinent, Pharmacia, Philanthropic, PM, Posaconazole, PPA, preceding, premised, pretax, psychotic, PTY, question, quota, rata, reassessed, reinvested, relinquished, Rewolinski, Rice, rig, RivoPharm, routine, salesforce, scientist, screening, se, sentence, Shaw, shortly, Solostar, SOP, South, stringent, succeed, Sunshine, superseded, syndrome, Travel, TRICARE, undergone, underway, unjust, unjustly, unrestricted, Upjohn, Vardenafil, Verapamil, Verelan, Veteran, vigorously, Virgin, Virginia, war, West, widened, wrongdoing, Zaroxolyn

Removed: Acetaminophen, acid, animal, applicant, AstraZeneca, automatic, Baby, belief, bioavailability, body, Boomer, broaden, certify, certiorari, chose, codifying, comparative, complied, concentrated, concentrating, conclusive, Concordia, condemnation, congestive, constituted, conversion, counterclaim, counterclaimed, cure, damaging, declaratory, declined, demonstrating, desist, detailing, determinable, diminished, disapprove, dispersed, DMF, dose, draft, edge, EHS, enabled, enhancing, enjoin, essential, exclude, exited, experimental, extensively, extraordinary, fire, franchise, furnished, gastroesophageal, gave, generation, generically, geographically, GLP, HCl, heart, heartburn, holder, hydromorphone, illustrating, IMS, IND, indefinite, initiation, inside, institution, intact, integrate, Inter, interchangeable, interpretation, interrupted, Investigational, irritation, Janssen, Kluwer, lab, Lanoxin, LCI, leaving, levied, levy, LIU, lived, Mallinckrodt, match, matter, metabolism, metro, ml, MMA, moderately, modest, Mutual, mutually, narrowing, nominated, noncontrolling, noncurrent, notably, novelty, occasion, optimal, overlap, passage, pediatric, pharmacokinetic, poppy, post, potent, pre, preclinical, predictable, prejudice, procedure, prohibition, proper, prospectively, prove, purport, PwC, rare, realizing, reestablish, referenced, reflux, regimen, Reinstatement, reject, requested, restoration, retiring, retroactively, retrospectively, run, satisfaction, seize, sequential, shape, showing, sponsor, stability, stage, standing, statistical, straw, studied, Suitability, supplemental, supportive, Supreme, suspend, synthesize, tentatively, tolerance, triennial, UK, unacceptable, undergo, undertaken, unfair, uninterrupted, Unithroid, USPTO, utility, Vanguard, voluntarily, Zomig

From filing 10-K 2019 FY